Mettler-Toledo International (NYSE:MTD) CFO Shawn Vadala Sells 1,000 Shares

Mettler-Toledo International, Inc. (NYSE:MTD) CFO Shawn Vadala sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total transaction of $1,511,000.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,990,168. This represents a 15.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shawn Vadala also recently made the following trade(s):

• On Monday, November 24th, Shawn Vadala sold 1,025 shares of Mettler-Toledo International stock. The shares were sold at an average price of $1,452.00, for a total value of $1,488,300.00.
• On Tuesday, November 11th, Shawn Vadala sold 1,895 shares of Mettler-Toledo International stock. The shares were sold at an average price of $1,455.52, for a total value of $2,758,210.40.

Mettler-Toledo International Trading Down 1.2%

MTD traded down $17.77 on Wednesday, hitting $1,488.26. The company had a trading volume of 35,062 shares, compared to its average volume of 164,806. The company’s fifty day moving average price is $1,356.38 and its 200 day moving average price is $1,268.12. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The firm has a market cap of $30.40 billion, a P/E ratio of 37.68, a PEG ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on MTD. Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Evercore ISI raised their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Finally, Stifel Nicolaus increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp lifted its stake in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the last quarter. Norges Bank acquired a new stake in Mettler-Toledo International during the second quarter worth approximately $360,126,000. Alliancebernstein L.P. lifted its position in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares during the last quarter. PineStone Asset Management Inc. lifted its position in Mettler-Toledo International by 41.9% in the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after acquiring an additional 98,737 shares during the last quarter. Finally, Rakuten Investment Management Inc. purchased a new position in Mettler-Toledo International during the 3rd quarter worth approximately $121,021,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.